Inflammx Therapeutics

Developer of therapeutics for ophthalmic disorders

placeTampa, Florida, United States calendar_todayFounded 2005 groups2 employees language inflammx.com

Innovation

2 patent families — focus: Human necessities; filing pace accelerating. Cited 8 times.

YearFilings
20221
20231
20241
20252

Social engagement

Social engagement: 285 social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

4 investors on record.

Investor typeCountShare
Venture capital4100%
Coming soon